Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panacea Biotec is one of India's largest biotechnology companies with a strong presence in vaccines and pharmaceuticals. It has over 120 marketed drugs across multiple therapeutic areas including oncology, nephrology/transplantation medicine, gastroenterology/pain management and diabetes. Its pipeline includes innovative vaccines such as BPBC Betacoronavirus vaccine for COVID‑19 prevention and DengiAll for dengue fever. The company also develops biosimilars/monoclonal antibodies. Clinical results vary by program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panacea Health.